These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 854153)

  • 41. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 39-1980.
    N Engl J Med; 1980 Oct; 303(14):803-9. PubMed ID: 7412787
    [No Abstract]   [Full Text] [Related]  

  • 42. Multiple system atrophy.
    Quinn N; Wenning G
    Br J Hosp Med; 1994 May 4-17; 51(9):492-4. PubMed ID: 7921508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [ON THE SUPRASPINAL EXTENSION OF LESIONS IN CHARCOT-MARIE-TOOTH ATROPHY].
    HARIGA J; COLLE G; GUAZZI GC
    Acta Neurol Psychiatr Belg; 1964 Jun; 64():617-32. PubMed ID: 14222366
    [No Abstract]   [Full Text] [Related]  

  • 44. [The neurological picture of olivopontocerebellar atrophy].
    Tarnowska-Dziduszko E
    Neuropatol Pol; 1970; 8(2):169-75. PubMed ID: 5425144
    [No Abstract]   [Full Text] [Related]  

  • 45. [Pseudosystemic lesions in "atypical" encephalitides].
    Jellinger K; Seitelberger F
    Acta Neuropathol; 1967 May; 8(2):185-209. PubMed ID: 6033098
    [No Abstract]   [Full Text] [Related]  

  • 46. Computed tomography of olivopontocerebellar degeneration.
    Savoiardo M; Bracchi M; Passerini A; Visciani A; Di Donato S; Cocchini F
    AJNR Am J Neuroradiol; 1983; 4(3):509-12. PubMed ID: 6410784
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Neuropathological background of spinocerebellar degeneration--with special reference to autonomic nervous system lesions in olivopontocerebellar atrophy, Shy-Drager syndrome and multiple system atrophy].
    Mizutani T
    No To Shinkei; 1985 Jul; 37(7):675-85. PubMed ID: 4063122
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is cranial computerized tomography useful in the diagnosis of multiple system atrophy?
    Wenning GK; Jäger R; Kendall B; Kingsley D; Daniel SE; Quinn NP
    Mov Disord; 1994 May; 9(3):333-6. PubMed ID: 8041375
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Autopsy case of familial cerebellar degeneration (Holmes' type) associated with degeneration of the putamen and substantia nigra].
    Nakamura H; Isaka K; Maeda S; Kishi Y
    Rinsho Shinkeigaku; 1975 Oct; 15(10):705-12. PubMed ID: 1241343
    [No Abstract]   [Full Text] [Related]  

  • 50. [High-field MR findings of multiple system atrophy].
    Tsuchiya K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Jul; 50(7):772-9. PubMed ID: 2235325
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dominant olivopontocerebellar atrophy with dementia and extrapyramidal signs: report of a family through three generations.
    Konigsmark BW; Lipton HL
    Birth Defects Orig Artic Ser; 1971 Feb; 7(1):178-91. PubMed ID: 5173358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Magnetic resonance imaging in spinocerebellar degeneration].
    Kojima S; Hirayama K
    No To Shinkei; 1988 Feb; 40(2):187-93. PubMed ID: 3163479
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies on neurotransmitter markers and neuronal cell density in the cerebellar system in olivopontocerebellar atrophy and cortical cerebellar atrophy.
    Kanazawa I; Kwak S; Sasaki H; Mizusawa H; Muramoto O; Yoshizawa K; Nukina N; Kitamura K; Kurisaki H; Sugita K
    J Neurol Sci; 1985 Dec; 71(2-3):193-208. PubMed ID: 2868072
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduction of noradrenaline in cerebellum of patients with olivopontocerebellar atrophy.
    Kish SJ; Shannak KS; Hornykiewicz O
    J Neurochem; 1984 May; 42(5):1476-8. PubMed ID: 6707646
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HLA and complement typing in olivo-ponto-cerebellar atrophy.
    Wastiaux JP; Lamoureux G; Bouchard JP; Durivage A; Barbeau C; Barbeau A
    Can J Neurol Sci; 1978 Feb; 5(1):75-81. PubMed ID: 647501
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anterior horn cell disease and olivopontocerebellar hypoplasia.
    Ryan MM; Cooke-Yarborough CM; Procopis PG; Ouvrier RA
    Pediatr Neurol; 2000 Aug; 23(2):180-4. PubMed ID: 11020648
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autonomic nerve calcification and peripheral neuropathy in olivopontocerebellar atrophy.
    Staal A; Stefanko SZ; Busch HF; Jennekens FG; De Bruinj WC
    J Neurol Sci; 1981 Sep; 51(3):383-94. PubMed ID: 7276985
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathological mechanisms in polyglutamine expansion diseases.
    Devys D; Yvert G; Lunkes A; Trottier Y; Mandel JL
    Adv Exp Med Biol; 2001; 487():199-210. PubMed ID: 11403159
    [No Abstract]   [Full Text] [Related]  

  • 59. The role of MRI in the diagnosis of olivopontocerebellar atrophy.
    Giuliani G; Chiaramoni L; Foschi N; Terziani S
    Ital J Neurol Sci; 1992 Mar; 13(2):151-6. PubMed ID: 1592576
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Olivopontocerebellar atrophy. Case report].
    Kostić V; Nikolić M; Simonović M
    Srp Arh Celok Lek; 1983 Jun; 111(6):835-40. PubMed ID: 6665629
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.